Vitamin K deficiency and osteopenia in disuse-affected limbs of vitamin D-deficient elderly stroke patients.

Bone mineral density is reduced in stroke patients on the hemiplegic and contralateral sides, reflecting a degree of paralysis and vitamin D deficiency. Because the deficiency of vitamin K, a factor essential for site-specific carboxylation of bone Gla protein, is also associated with reduced bone mineral density, an additional contribution of vitamin K to bone changes was assessed in 168 elderly patients with long-standing post-stroke hemiplegia and hypovitaminosis D. Sera were analyzed to relate vitamin K1 concentrations to bone-related biochemical indexes and bone mineral density measured by radiodensitometry of the second metacarpal. Bone mineral density was lower on both sides in patients than in the 56 controls (P < 0.02). Serum vitamin K1 concentrations, which correlated positively with bone Gla protein concentrations (P < 0.0001), were lower in patients (0.48 +/- 0.47 nmol/L) than controls (1.33 +/- 0.49; P < 0.0001). Serum bone Gla protein and 25-hydroxyvitamin D concentrations were lower in patients than controls (P < 0.0001), whereas ionized Ca concentrations were higher in patients (1.277 +/- 0.041 mmol/L) than controls (1.210 +/- 0.049; P < 0.0001), correlating with the Barthel index. Multivariate linear regression identified vitamin K1, bone Gla protein, 25-hydroxyvitamin D, ionized calcium, and the Barthel index as independent bone mineral density determinants on the hemiplegic side and 25-hydroxyvitamin D, calcium, and the Barthel index on the intact side. Immobilization and vitamin K deficiency had stronger osteopenic effects on the hemiplegic side than contralaterally.

[1]  G. Mulley,et al.  Hip fracture after hemiplegia. , 1979, Postgraduate medical journal.

[2]  Connor Tb,et al.  Immobilization hypercalcemia. Some new aspects of diagnosis and treatment. , 1973 .

[3]  Yoshihiro Sato,et al.  High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease [RETRACTED] , 1997, Neurology.

[4]  H. Maruoka,et al.  Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. , 1996, Stroke.

[5]  Yoshihiro Sato,et al.  Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke , 1998, Journal of the Neurological Sciences.

[6]  P. Price,et al.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. , 1981, The Journal of biological chemistry.

[7]  L. Klenerman,et al.  Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. , 1985, The Journal of clinical endocrinology and metabolism.

[8]  M. Bots,et al.  Vitamin K Status and Bone Mass in Women With and Without Aortic Atherosclerosis: A Population-Based Study , 1996, Calcified Tissue International.

[9]  H. Maruoka,et al.  Development of osteopenia in the hemiplegic finger in patients with stroke. , 1996, European neurology.

[10]  Yoshihiro Sato,et al.  Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in elderly patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[11]  K. Oizumi,et al.  Accelerated bone remodeling in patients with poststroke hemiplegia. , 1998, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[12]  S. P. Chow,et al.  A prospective study on hip fractures in patients with previous cerebrovascular accidents. , 1992, Injury.

[13]  Lippincott Williams Wilkins,et al.  Multicenter Trial of Hemodilution in Ischemic Stroke — Background and Study Protocol , 1985, Stroke.

[14]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[15]  C. Vermeer,et al.  Role of vitamin K in bone metabolism. , 1995, Annual review of nutrition.

[16]  J. Lian,et al.  The vitamin K-dependent synthesis of gamma-carboxyglutamic acid by bone microsomes. , 1978, The Journal of biological chemistry.

[17]  M. Shearer,et al.  Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck. , 1991, Bone.

[18]  J L Kelsey,et al.  Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. , 1991, The New England journal of medicine.

[19]  J. Hart,et al.  Circulating vitamin K levels in patients with fractures. , 1988, The Journal of bone and joint surgery. British volume.

[20]  K. Hamulýak,et al.  The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. , 1989, Annals of internal medicine.

[21]  P. Delmas,et al.  Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  P. Delmas,et al.  Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  F. Saji,et al.  Serum vitamin K level and bone mineral density in post‐menopausal women , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[24]  P. Delmas,et al.  Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  P. Delmas,et al.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. , 1993, The Journal of clinical investigation.

[26]  P. Price,et al.  1,25-Dihydroxyvitamin D3 stimulates the synthesis of matrix gamma-carboxyglutamic acid protein by osteosarcoma cells. Mutually exclusive expression of vitamin K-dependent bone proteins by clonal osteoblastic cell lines. , 1988, The Journal of biological chemistry.

[27]  P. Price,et al.  The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells. , 1984, The Journal of biological chemistry.

[28]  A. F. Stewart,et al.  Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. , 1982, The New England journal of medicine.

[29]  L. Mosekilde,et al.  Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  Yoshihiro Sato,et al.  Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation. , 1997, Stroke.

[31]  U. Tjaden,et al.  Improved method for the determination of vitamin K1 epoxide in human plasma with electrofluorimetric reaction detection. , 1984, Journal of chromatography.

[32]  K. Oizumi,et al.  Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. , 1998, Bone.

[33]  J. Poser,et al.  Characterization of a gamma-carboxyglutamic acid-containing protein from bone. , 1976, Proceedings of the National Academy of Sciences of the United States of America.